{
    "eid": "2-s2.0-85153553148",
    "title": "Immunogenicity and protective efficacy of SARS-CoV-2 mRNA vaccine encoding secreted non-stabilized spike in female mice",
    "cover-date": "2023-12-01",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Chemistry (all)",
            "@code": "1600",
            "@abbrev": "CHEM"
        },
        {
            "@_fa": "true",
            "$": "Biochemistry, Genetics and Molecular Biology (all)",
            "@code": "1300",
            "@abbrev": "BIOC"
        },
        {
            "@_fa": "true",
            "$": "Physics and Astronomy (all)",
            "@code": "3100",
            "@abbrev": "PHYS"
        }
    ],
    "keywords": [],
    "authors": [
        "Eakachai Prompetchara",
        "Chutitorn Ketloy",
        "Mohamad Gabriel Alameh",
        "Kittipan Tharakhet",
        "Papatsara Kaewpang",
        "Nongnaphat Yostrerat",
        "Patrawadee Pitakpolrat",
        "Supranee Buranapraditkun",
        "Suwimon Manopwisedjaroen",
        "Arunee Thitithanyanont",
        "Anan Jongkaewwattana",
        "Taweewan Hunsawong",
        "Rawiwan Im-Erbsin",
        "Matthew Reed",
        "Wassana Wijagkanalan",
        "Kanitha Patarakul",
        "Teerasit Techawiwattanaboon",
        "Tanapat Palaga",
        "Kieu Lam",
        "James Heyes",
        "Drew Weissman",
        "Kiat Ruxrungtham"
    ],
    "citedby-count": 1,
    "ref-count": 73,
    "ref-list": [
        "The COVID-19 Pandemic: A Comprehensive Review of Taxonomy, Genetics, Epidemiology, Diagnosis, Treatment, and Control",
        "Prevalence of Asymptomatic SARS-CoV-2 Infection",
        "Global Percentage of Asymptomatic SARS-CoV-2 Infections Among the Tested Population and Individuals With Confirmed COVID-19 Diagnosis: A Systematic Review and Meta-analysis",
        "Magnitude of asymptomatic COVID-19 cases throughout the course of infection: A systematic review and meta-analysis",
        "Substantial undocumented infection facilitates the rapid dissemination of novel coronavirus (SARS-CoV-2)",
        "SARS-CoV-2, SARS-CoV, and MERS-CoV viral load dynamics, duration of viral shedding, and infectiousness: a systematic review and meta-analysis",
        "SARS-COV-2 Variants: Differences and Potential of Immune Evasion",
        "Real-world effectiveness of COVID-19 vaccines: a literature review and meta-analysis",
        "Comparing the clinical efficacy of COVID-19 vaccines: a systematic review and network meta-analysis",
        "Duration of effectiveness of vaccines against SARS-CoV-2 infection and COVID-19 disease: results of a systematic review and meta-regression",
        "Prediction of long-term kinetics of vaccine-elicited neutralizing antibody and time-varying vaccine-specific efficacy against the SARS-CoV-2 Delta variant by clinical endpoint",
        "Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine",
        "Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine",
        "Potent neutralizing antibodies against multiple epitopes on SARS-CoV-2 spike",
        "Immune Response to SARS-CoV-2 Vaccines",
        "SARS-CoV-2 infection of human ACE2-transgenic mice causes severe lung inflammation and impaired function",
        "COVID-19 treatments and pathogenesis including anosmia in K18-hACE2 mice",
        "Pathogenesis of SARS-CoV-2 in Transgenic Mice Expressing Human Angiotensin-Converting Enzyme 2",
        "Prolonged Protective Immunity Induced by Mild SARS-CoV-2 Infection of K18-hACE2 Mice",
        "Protection of K18-hACE2 mice and ferrets against SARS-CoV-2 challenge by a single-dose mucosal immunization with a parainfluenza virus 5-based COVID-19 vaccine",
        "A Thermostable mRNA Vaccine against COVID-19",
        "RBD-VLP Vaccines Adjuvanted with Alum or SWE Protect K18-hACE2 Mice against SARS-CoV-2 VOC Challenge",
        "Selective expansion of high- or low-avidity cytotoxic T lymphocytes and efficacy for adoptive immunotherapy",
        "Role of antigen, CD8, and cytotoxic T lymphocyte (CTL) avidity in high dose antigen induction of apoptosis of effector CTL",
        "High-avidity CTL exploit two complementary mechanisms to provide better protection against viral infection than low-avidity CTL",
        "Protective activity of mRNA vaccines against ancestral and variant SARS-CoV-2 strains",
        "SARS-CoV-2 spike-protein D614G mutation increases virion spike density and infectivity",
        "Immunogenicity and structures of a rationally designed prefusion MERS-CoV spike antigen",
        "SARS-CoV-2 spike glycoprotein vaccine candidate NVX-CoV2373 immunogenicity in baboons and protection in mice",
        "Safety and Immunogenicity of Two RNA-Based Covid-19 Vaccine Candidates",
        "An mRNA Vaccine against SARS-CoV-2 - Preliminary Report",
        "ChAdOx1 nCoV-19 vaccine prevents SARS-CoV-2 pneumonia in rhesus macaques",
        "Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial",
        "Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002): a single-blind, randomised, controlled, phase 2/3 trial",
        "Native-like SARS-CoV-2 Spike Glycoprotein Expressed by ChAdOx1 nCoV-19/AZD1222 Vaccine",
        "Respiratory syncytial virus disease in infants despite prior administration of antigenic inactivated vaccine",
        "Immunization with SARS coronavirus vaccines leads to pulmonary immunopathology on challenge with the SARS virus",
        "Immunization with inactivated Middle East Respiratory Syndrome coronavirus vaccine leads to lung immunopathology on challenge with live virus",
        "Prefusion RSV F Immunization Elicits Th2-Mediated Lung Pathology in Mice When Formulated With a Th2 (but Not a Th1/Th2-Balanced) Adjuvant Despite Complete Viral Protection",
        "Omicron spike function and neutralizing activity elicited by a comprehensive panel of vaccines",
        "Antibody escape of SARS-CoV-2 Omicron BA.4 and BA.5 from vaccine and BA.1 serum",
        "BA.2.12.1, BA.4 and BA.5 escape antibodies elicited by Omicron infection",
        "Immunogenicity and safety of heterologous versus homologous prime-boost schedules with an adenoviral vectored and mRNA COVID-19 vaccine: a systematic review",
        "Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials",
        "Comparative immunogenicity and reactogenicity of heterologous ChAdOx1-nCoV-19-priming and BNT162b2 or mRNA-1273-boosting with homologous COVID-19 vaccine regimens",
        "New crop of COVID-19 mRNA vaccines could be easier to store, cheaper to use",
        "SARS-CoV-2 delta variant infection in domestic dogs and cats, Thailand",
        "DNA Vaccine Administered by Cationic Lipoplexes or by In Vivo Electroporation Induces Comparable Antibody Responses against SARS-CoV-2 in Mice",
        "CoronaVac induces lower neutralising activity against variants of concern than natural infection",
        "A Multi-Targeting, Nucleoside-Modified mRNA Influenza Virus Vaccine Provides Broad Protection in Mice",
        "A Facile Method for the Removal of dsRNA Contaminant from In Vitro-Transcribed mRNA",
        "Expression kinetics of nucleoside-modified mRNA delivered in lipid nanoparticles to mice by various routes",
        "Nanomaterial Delivery Systems for mRNA Vaccines",
        "The ChAdOx1 vectored vaccine, AZD2816, induces strong immunogenicity against SARS-CoV-2 beta (B.1.351) and other variants of concern in preclinical studies",
        "ChAdOx1 nCoV-19 (AZD1222) or nCoV-19-Beta (AZD2816) protect Syrian hamsters against Beta Delta and Omicron variants",
        "Translating a Thin-Film Rehydration Method to Microfluidics for the Preparation of a SARS-CoV-2 DNA Vaccine: When Manufacturing Method Matters",
        "SARS-CoV-2 neutralizing antibodies decline over one year and patients with severe COVID-19 pneumonia display a unique cytokine profile",
        "A Single-Cycle Influenza A Virus-Based SARS-CoV-2 Vaccine Elicits Potent Immune Responses in a Mouse Model",
        "Pseudotype Neutralization Assays: From Laboratory Bench to Data Analysis",
        "Limited and Short-Lasting Virus Neutralizing Titers Induced by Inactivated SARS-CoV-2 Vaccine",
        "DNA vaccine candidate encoding SARS-CoV-2 spike proteins elicited potent humoral and Th1 cell-mediated immune responses in mice"
    ],
    "affiliation": [
        {
            "affiliation-city": "Bangkok",
            "@id": "60002620",
            "affilname": "Faculty of Medicine, Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60002620",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60028190",
            "affilname": "Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60016185",
            "affilname": "Armed Forces Research Institute of Medical Sciences, Thailand",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60016185",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Nakhon Pathom",
            "@id": "60012718",
            "affilname": "Mahidol University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60012718",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Pathum Thani",
            "@id": "60011947",
            "affilname": "Thailand National Center for Genetic Engineering and Biotechnology",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60011947",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Philadelphia",
            "@id": "60003711",
            "affilname": "University of Pennsylvania Perelman School of Medicine",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60003711",
            "affiliation-country": "United States"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "129575167",
            "affilname": "USAMD-AFRIMS",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/129575167",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Vancouver",
            "@id": "124583530",
            "affilname": "Genevant Sciences Corporation",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/124583530",
            "affiliation-country": "Canada"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "119943544",
            "affilname": "Ltd.",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/119943544",
            "affiliation-country": "Thailand"
        }
    ],
    "funding": [
        "Chula VRC",
        "Government of Thailand",
        "National Vaccine Institute",
        "Ratchadapiseksompotch Fund",
        "Second Century Fund",
        "Chulalongkorn University",
        "National Research Council of Thailand NRCT",
        "Faculty of Medicine, Chulalongkorn University"
    ]
}